- Latest weekly return ranks in the strongest part of its sector group.
IUI1
GER
Week ended 07 Aug 2026
Weekly Investor Report
Intuitive Surgical, Inc. · Healthcare · Medical Instruments & Supplies
Latest close
326.6 EUR
7.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -14.9% below the Trend Line and sits at 16.0% of its 52-week range. The latest completed week returned 7.1%, after a -7.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 52/100.
Setup score
23
out of 100
Latest Close
326.6 EUR
7 Aug 2026
1W Return
7.1%
latest completed week
4W Return
-7.9%
short-term follow-through
12W Return
-10.4%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.1%
Latest completed week; four-week move -7.9%.
Indicator stack
8/28
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
52/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -14.9% below the Trend Line and sits at 16.0% of its 52-week range. The latest completed week returned 7.1%, after a -7.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.01
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.9% over four weeks, -10.4% over 12 weeks, and -18.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.03Latest activity-pressure read.
Pressure change-49.3%Four-week change in activity pressure.
Leadership-25.98Latest relative-leadership reading.
RS change-46.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 85%
Model confidence 79%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality85/100Profitability and accounting quality. Underlying universe rank 16; rank 1 is best.
Momentum19/100Medium-term price momentum. Underlying universe rank 82; rank 1 is best.
Growth94/100Revenue and earnings growth. Underlying universe rank 7; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework19/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 39.3x Price divided by trailing earnings.
- Price / sales
- 11.1x Market value relative to trailing revenue.
- EV / EBITDA
- 29.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 2.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 66.3% Gross profit retained from each unit of revenue.
- Operating margin
- 30.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 26.8% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 20.5% Latest one-year revenue growth.
- EPS growth
- 23.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 91.0% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 2.6% Net share repurchases relative to market value.
- Shareholder yield
- 2.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 25 relevant articles.
4 positive · 19 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-36.7%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+7.1%Week of 7 Aug.
Worst week-13.3%Week of 17 Jul.
Latest week+7.1%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains12
Flat weeks0
Modest losses6
Sharp losses7
Recent vol5.1%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Healthcare
4-week rank70 / 78
Group average1.4%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD69.2%positive activity pressure
RS34.6%positive relative leadership
Four-week leaders
IndustryDE Medical Instruments & Supplies
4-week rank12 / 12
Group average0.3%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD75.0%positive activity pressure
RS8.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape21/100
Trend, activity pressure, participation, and risk combine to a 21/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Factors29/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 16 SVQF19/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 304.5 of 375 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 25 relevant articles.
Intuitive Surgical (NASDAQ: ISRG) EVP sells 56 shares in planned trades Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 326.6 EUR | 7.1% | 383.9 EUR | 406.3 EUR | -1.03 | -25.98 | 2.6K | Off |
| 31 Jul 2026 | 305.0 EUR | 1.9% | 389.6 EUR | 405.9 EUR | -0.87 | -29.37 | 3.4K | Off |
| 24 Jul 2026 | 299.4 EUR | -2.6% | 395.3 EUR | 405.8 EUR | -0.62 | -29.68 | 7.1K | Off |
| 17 Jul 2026 | 307.2 EUR | -13.3% | 401.7 EUR | 405.8 EUR | -0.59 | -27.50 | 5.9K | Off |
| 10 Jul 2026 | 354.5 EUR | -4.4% | 407.6 EUR | 405.8 EUR | -0.69 | -17.68 | 2.0K | Off |
| 3 Jul 2026 | 370.9 EUR | 4.0% | 411.1 EUR | 405.5 EUR | -0.94 | -16.64 | 236 | Off |
| 26 Jun 2026 | 356.8 EUR | 0.8% | 415.2 EUR | 405.1 EUR | -1.16 | -16.66 | 310 | Off |
| 19 Jun 2026 | 353.9 EUR | 0.5% | 419.6 EUR | 404.8 EUR | -1.17 | -18.81 | 5 | Off |
| 12 Jun 2026 | 352.2 EUR | -4.7% | 424.0 EUR | 404.4 EUR | -1.14 | -18.48 | 305 | Off |
| 5 Jun 2026 | 369.6 EUR | 2.5% | 428.2 EUR | 404.1 EUR | -1.07 | -15.31 | 213 | Off |
| 29 May 2026 | 360.7 EUR | -4.3% | 431.9 EUR | 403.6 EUR | -1.04 | -18.96 | 1.5K | Off |
| 22 May 2026 | 377.0 EUR | 3.4% | 435.3 EUR | 403.1 EUR | -1.00 | -15.10 | 1.1K | Off |
| 15 May 2026 | 364.6 EUR | -4.4% | 438.5 EUR | 402.5 EUR | -0.78 | -15.13 | 2.1K | Off |
| 8 May 2026 | 381.4 EUR | -1.4% | 439.0 EUR | 402.1 EUR | -0.83 | -13.20 | 1.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.